Trial Profile
Intragastric pH required to prevent aspirin-induced oesophageal damage in Japanese subjects receiving aspirin +/- rabeprazole or lansoprazole
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2011
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Lansoprazole (Primary) ; Rabeprazole (Primary)
- Indications Embolism and thrombosis; Oesophageal injury
- Focus Adverse reactions; Pharmacodynamics
- 12 Mar 2011 New trial record